Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pure Bioscience (PURE)
OTHER OTC:PURE
Holding PURE?
Track your performance easily
PURE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.06 - $0.16
Previous Close$0.07
Volume56.61K
Average Volume (3M)32.39K
Market Cap
$8.22M
Enterprise Value$7.87M
Total Cash (Recent Filing)$349.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.50
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding111,856,473
10 Day Avg. Volume33,565
30 Day Avg. Volume32,387
Standard Deviation0.26
R-Squared0.00
Alpha0.00935
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-2.11
Price to Sales (P/S)3.99
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.01
Enterprise Value/Gross Profit6.83
Enterprise Value/Ebitda-2.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pure Bioscience News
Ownership Overview
38.98%
Insiders
0.69% Other Institutional Investors
60.33% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PURE FAQ
What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.06 and its highest was $0.16 in the past 12 months.
What is Pure Bioscience’s market cap?
Currently, no data Available
When is Pure Bioscience’s upcoming earnings report date?
Pure Bioscience’s upcoming earnings report date is Mar 12, 2025 which is in 79 days.
How were Pure Bioscience’s earnings last quarter?
Currently, no data Available
Is Pure Bioscience overvalued?
According to Wall Street analysts Pure Bioscience’s price is currently Overvalued.
Does Pure Bioscience pay dividends?
Pure Bioscience does not currently pay dividends.
What is Pure Bioscience’s EPS estimate?
Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pure Bioscience have?
Pure Bioscience has 117,381,470 shares outstanding.
What happened to Pure Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pure Bioscience?
Currently, no hedge funds are holding shares in PURE
---
Pure Bioscience Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-50.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-55.18%
Trailing 12-Months
Company Description
Pure Bioscience
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
---
Technical Analysis
---